Corporate
Non-Fungible Tokens: digital commercialisation with caveats
What are non-fungible tokens (NFTS) and what are the copyright issues around owning an NFT?
Protecting IP in plant-based ‘meat-substitutes’
Innovation in the plant-based meat sector is aiming to help to solve some of the problems associated with animal-meat production.
Protecting IP in lab-grown organs – organoids
Lab-grown miniature organs (also known as organoids) is a technology area that has the potential to significantly lower costs and failure rates in drug development, and to improve safety.
Inside Green Innovation: Progress Report 2021
What can patent data reveal about global progress in green innovation, and what might be achieved in years to come?
Who are the players in the digital healthcare space for medicine development? An analysis of patent filing trends
In this article, we look at some of the recent patenting trends and challenges in the digital healthcare space, with a spotlight on digital healthcare for medicine development.
G02/21 Plausibility
A new EPO referral to the enlarged BoA will determine whether post-filed data can be used to support inventive step and plausibility.
